Prognostic Indicators of Survival Following Cardiopulmonary Resuscitation in Patients With Cardiac Arrest
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03597425 |
|
Recruitment Status : Unknown
Verified July 2018 by GengLong Liu, First Affiliated Hospital, Sun Yat-Sen University.
Recruitment status was: Recruiting
First Posted : July 24, 2018
Last Update Posted : July 24, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Cardiopulmonary Resuscitation | Procedure: Cardiopulmonary resuscitation |
A CPR coordinator prospectively collected data for the CPR registry according to the Utstein-style guidelines. Te registry included the following information:
demographic data, comorbidities, whether the arrest was witnessed, the incidence of suspected or confrmed trauma, presumed arrest time; presence of bystander CPR, frst documented arrest rhythm by the emergency medical service (EMS) provider, any return of spontaneous circulation (ROSC), presence of ECPR, the presence of return of spontaneous heart beating (ROSB) after CPR, presumed cause of arrest; the application of therapeutic hypothermia and the use of coronary angiography(CAG) or percutaneous coronary intervention (PCI),24-hour survival, the presence of ROSC more than 20 min, hospital length of stay (LOS), survival to hospital discharge,Glasgow-Pittsburgh cerebral performance category (CPC) score at discharge, and the fnal diagnosis at discharge. Te comorbidity score was calculated using the Charlson comorbidity index. Te duration of CPR was defned as the time interval from the frst chest compression provided by healthcare providers to the termination of resuscitation eforts due to ROSC (more than 20 min),ROSB after CPR, or a declaration of death. A favorable neurologic outcome was defned as a CPC score of 1 or 2 on the fve-category scale.
| Study Type : | Observational |
| Estimated Enrollment : | 120 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Prognostic Indicators of Survival Following Cardiopulmonary Resuscitation in Patients With Cardiac Arrest: a Single-institutional Study |
| Actual Study Start Date : | January 1, 2017 |
| Estimated Primary Completion Date : | January 1, 2020 |
| Estimated Study Completion Date : | January 1, 2020 |
- Procedure: Cardiopulmonary resuscitation
Cardiopulmonary resuscitation (CPR) is an emergency treatment for patients with respiratory arrest and cardiac arrest in an attempt to restore the patient to spontaneous breathing and heartbeat through cardiopulmonary resuscitation
- indicators of survival [ Time Frame: an average of 1 year ]The survival outcome was analyzed with logstic regression
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- age more than 18 years,
- sudden arrest with potentially reversible causes,
- a short no fow time (time interval from presumed arrest to CPR initiation)
- even for unwitnessed arrests
Exclusion Criteria:
- presence of a terminal illness or malignancy, severe irreversible neurologic defcit,
- suspected or confrmed traumatic origin of arrest,
- no informed consent from the family
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03597425
| Contact: Genglong Liu, MD | +8615626405844 | lglong3@mail2.sysu.edu.cn |
| China, Guangdong | |
| Genglong Liu | Recruiting |
| Shunde, Guangdong, China | |
| Contact: Genglong Liu, MD +8615626405844 lglong3@mail2.sysu.edu.cn | |
| Study Chair: | Genglong Liu | Shunde Hospital of Southern Medical University |
| Responsible Party: | GengLong Liu, Principal Investigator, First Affiliated Hospital, Sun Yat-Sen University |
| ClinicalTrials.gov Identifier: | NCT03597425 |
| Other Study ID Numbers: |
cardiopulmonary resuscitation |
| First Posted: | July 24, 2018 Key Record Dates |
| Last Update Posted: | July 24, 2018 |
| Last Verified: | July 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Cardiac arrest Cardiopulmonary resuscitation Survival Prediction |
|
Heart Arrest Heart Diseases Cardiovascular Diseases |

